People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Calyxo, Inc. | — | Other Health Care | Series C | $115.9M | $204.7M | 2022 |
Chris Buchko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Buchko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Calvin Goforth | 1 | 25 |
| Ryan Drant | 1 | 24 |
| Jee Shin | 1 | 2 |
| Douglas Hughes | 1 | 2 |
| Dave Amerson | 1 | 1 |
| Joe Catanese | 1 | 1 |
| Jacob Garfield | 1 | 1 |
| Ryan Calvin Drant | 1 | 1 |
| Beverly Calvin Huss | 1 | 1 |
| Douglas Calvin Hughes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.